Dr. Reddy's Laboratories Announces Q1FY27 Results Release and Earnings Call Details

Dr. Reddy's Laboratories Announces Q1FY27 Results Release and Earnings Call Details

Dr. Reddy's Laboratories Announces Q1FY27 Results Release and Earnings Call Details​

Hyderabad: Dr. Reddy's Laboratories Ltd. has announced the release of its financial results for the quarter ending June 30, 2026. The company will release these Q1FY27 results on Wednesday, July 22, 2026, following a Board Meeting.

The company also scheduled an earnings call to discuss its financial performance subsequent to the results announcement.

Dr. Reddy's Laboratories Ltd. (stock codes including BSE: 500124 and NYSE: RDY) is set to host the earnings call on Wednesday, July 22, 2026. The meeting is scheduled for 19:30 PM IST / 10:00 AM ET.

A summary of the related events has been provided by the company:

EventDate and TimeAvailability Medium
Release of Financial ResultsWednesday, July 22, 2026, after Board MeetingStock Exchange, Media, Company Website, Email
Earnings CallWednesday, July 22, 2026 at 19:30 PM IST / 10:00 AM ETHosted by the Company
Press Meet Presentation & Audio/Transcript of the Earnings callTo be available on the Company's WebsiteStock Exchange, Company's Website www.drreddys.com

Following the release of its financial performance, Dr. Reddy's management will conduct an earnings call to address stakeholders and discuss the company's operational results for the quarter ended June 30, 2026. Details regarding pre-registration for the earnings call are available on the company’s platform.

DRREDDY Stock Price Movement​

As of 2:43 PM, shares of Dr. Reddy's Laboratories Limited are slipping by 0.92% in live trading, currently standing at ₹1232.8. The stock saw significant activity during the day, with a total traded volume amounting to 1.67 million shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top